<SEC-DOCUMENT>0001193125-19-307720.txt : 20191206
<SEC-HEADER>0001193125-19-307720.hdr.sgml : 20191206
<ACCEPTANCE-DATETIME>20191206072933
ACCESSION NUMBER:		0001193125-19-307720
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20191205
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20191206
DATE AS OF CHANGE:		20191206

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NN INC
		CENTRAL INDEX KEY:			0000918541
		STANDARD INDUSTRIAL CLASSIFICATION:	BALL & ROLLER BEARINGS [3562]
		IRS NUMBER:				621096725
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23486
		FILM NUMBER:		191271708

	BUSINESS ADDRESS:	
		STREET 1:		207 MOCKINGBIRD LANE
		CITY:			JOHNSON CITY
		STATE:			TN
		ZIP:			37604
		BUSINESS PHONE:		423-434-8300

	MAIL ADDRESS:	
		STREET 1:		207 MOCKINGBIRD LANE
		CITY:			JOHNSON CITY
		STATE:			TN
		ZIP:			37604

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NN BALL & ROLLER INC
		DATE OF NAME CHANGE:	19940203
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d842748d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">8-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO SECTION&nbsp;13 OR 15(d) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): December&nbsp;6, 2019 (December 5, 2019) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g842748g1206095931913.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>NN, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">000-23486</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">62-1096725</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or Other Jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of Incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>6210 Ardrey Kell Road</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Charlotte, North Carolina</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>28277</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(980) <FONT STYLE="white-space:nowrap">264-4300</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s telephone number, including area code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Former name or former address, if changed since last report) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Check the appropriate box if the Form <FONT STYLE="white-space:nowrap">8-K</FONT> filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Soliciting material pursuant to Rule <FONT STYLE="white-space:nowrap">14a-12</FONT> under the Exchange Act
(17 CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT
STYLE="white-space:nowrap">14d-2(b)</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14d-</FONT> 2(b)) </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT
STYLE="white-space:nowrap">13e-4(c)</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.13e-</FONT> 4(c)) </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Securities registered pursuant to Section&nbsp;12(b) of the Act: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title of each class</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Trading</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>symbol</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Name of each exchange</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>on which registered</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock,</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>par value $0.01</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>NNBR</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Nasdaq Stock</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Market LLC</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the
Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Securities Exchange Act of 1934 <FONT STYLE="white-space:nowrap">(&#167;240.12b-2</FONT> of this chapter). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Emerging growth company.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;&nbsp;&#9744;</P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>ITEM&nbsp;1.01.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On December&nbsp;5, 2019, NN, Inc., a Delaware corporation (the &#147;Company&#148;), entered into a securities purchase
agreement (the &#147;Purchase Agreement&#148;) with affiliates of Corre Partners Management, L.L.C. and Legion Partners Asset Management, LLC (&#147;Legion&#148;) (collectively, the &#147;Investors&#148;), pursuant to which the Company has agreed to
sell 100,000 shares of the Company&#146;s newly designated Series B Convertible Preferred Stock, par value $0.01 per share (the &#147;Series B Preferred Stock&#148;), at a price of $1,000 per share, together with common stock purchase warrants (the
&#147;Warrants&#148;) to purchase 1,500,000 shares of the Company&#146;s common stock, par value $0.01 per share (&#147;Common Stock&#148;), to the Investors for aggregate gross proceeds of $100&nbsp;million to the Company (the &#147;Financing
Transaction&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The closing of the Financing Transaction is expected to take place on or about December&nbsp;10,
2019, and is subject to customary closing conditions. The Company intends to use the proceeds from the Financing Transaction to repay all or a part of the outstanding amounts under the Company&#146;s senior secured revolving credit facility, to
prepay the Company&#146;s term loans, to pay any fees (in connection with a possible extension of the maturity date of the Company&#146;s senior debt, the repayment of the senior secured revolving credit facility, prepayment of the term loans and
the Financing Transaction), and for general corporate purposes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Purchase Agreement </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Purchase Agreement contains representations and warranties by the Company and the Investors and covenants of the Company
and the Investors (including indemnification from the Company in the event of breaches of its representations and warranties) and other rights, obligations and restrictions, which the Company believes are customary for transactions of this type.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Stockholder Approval</I>:<I> </I>Pursuant to the Purchase Agreement, the Company has agreed at the 2020 annual meeting
of the stockholders of the Company to include in its proxy statement (the &#147;Proxy Statement&#148;) prepared and filed with the Securities and Exchange Commission (the &#147;SEC&#148;) a proposal for approval by the holders of Common Stock that
is required under listing standards of Nasdaq to approve the issuance of Common Stock upon exercise of the Warrants and conversion or redemption of the Series B Preferred Stock of the Company issued to the Investors pursuant to the Purchase
Agreement (the &#147;Stockholder Approval&#148;). Subject to the directors&#146; fiduciary duties, the Proxy Statement shall include the recommendation from the Company&#146;s Board of Directors that the stockholders vote in favor of the Stockholder
Approval. The Company shall use its reasonable best efforts to solicit from the stockholders proxies in favor of the Stockholder Approval and to obtain the Stockholder Approval. The Company has also agreed to use commercially reasonable efforts to
increase the number of authorized shares of Common Stock at the Company&#146;s 2023 annual meeting of stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Consent Rights</I>: Pursuant to the Purchase Agreement, the Company has agreed with each Investor, subject to certain
exceptions, not to become party to certain change in control transactions other than transactions in which holders of shares of the Series B Preferred Stock are entitled to receive cash in an amount equal to the applicable redemption value plus
accrued and unpaid dividends (and less a portion of certain dividend taxes that may be paid or accrued by the Company on behalf of the Investors in respect of the Series B Preferred Stock) (such a change in control transaction, a &#147;Qualifying
Transaction&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Additional Agreements</I>: The Purchase Agreement contains additional agreements and covenants
between the Company and the Purchasers, including restrictions similar to those in the Certificate of Designation regarding dividends and voting rights. In addition, the Company agreed that it will use reasonable best efforts to amend and extend its
existing amended and restated credit agreement as soon as practicable after the closing of the Financing Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Standstill Exemption</I>: In connection with the Financing Transaction, the Company and Legion have agreed that Legion is
exempted from its 9.9% standstill obligation set forth in the Cooperation Agreement dated as of February&nbsp;25, 2019, between the Company and Legion. Legion, however, remains subject to beneficial ownership limitations applicable to each of the
Investors pursuant to the Financing Transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The foregoing description of the Purchase Agreement has been included to
provide investors with information regarding its terms. It is not intended to provide any factual information about the parties to the agreement or the Company&#146;s business. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Certificate of Designation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The terms of the Series B Preferred Stock will be set forth in a Certificate of Designation, a summary of which is set forth
below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Security:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Series&nbsp;B&nbsp;Convertible
Preferred&nbsp;Stock,&nbsp;par&nbsp;value&nbsp;$0.01&nbsp;per&nbsp;share</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Series B Dividend:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">10.625% per annum, payable quarterly in arrears; provided that if the Company does not obtain Stockholder
Approval prior to the earlier of (i)&nbsp;June&nbsp;30, 2020 and (ii)&nbsp;at the Company&#146;s 2020 annual meeting of stockholders, the rate shall increase to 11.625% per annum until such Stockholder Approval has been obtained. Series B Preferred
Stock will fully participate on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis in any dividends paid on the Common Stock, using a conversion rate based on a fixed conversion price equal to $7.91.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Redemption:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Company may redeem the shares of Series B Preferred Stock for an amount equal to the applicable redemption
price set forth below expressed as a percentage of its Liquidation Preference (as defined below), plus any accrued and unpaid Series B Dividends, minus any dividend withholding taxes that the Company is entitled to set off pursuant to the terms of
the Purchase Agreement.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><U>Year</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><U>Percentage of Liquidation Preference</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#cceeff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">On or before March&nbsp;31, 2021</P></TD>
<TD VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" BGCOLOR="#cceeff">105%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">After March&nbsp;31, 2021 and<BR>on or before December&nbsp;31, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">110%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#cceeff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">After December&nbsp;31, 2021 and<BR>on or before December&nbsp;31,
2022</P></TD>
<TD VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" BGCOLOR="#cceeff">120%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">After December&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">130%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The March&nbsp;31, 2021 date shall be deemed May&nbsp;15, 2021 if the Company has entered into a definitive
agreement with respect to a transaction that constitutes a Change of Control (as defined in the Purchase Agreement) on or prior to March&nbsp;31, 2021. The redemption price and any accrued and unpaid dividends shall be paid in cash unless the
Company&#146;s outstanding shares of Common Stock have a market capitalization in excess of $750&nbsp;million on the date of the redemption notice, in which case the redemption price may be paid in cash or a combination of cash and shares of Common
Stock; provided that the number of shares of Common Stock to be delivered will be determined based on 95% of the <FONT STYLE="white-space:nowrap">30-trading</FONT> day volume-weighted average price (&#147;VWAP&#148;).</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Conversion Rights/Rates:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Conversion rate equals (i)&nbsp;the Liquidation Preference, plus any accrued and unpaid Series B Dividends, less
any dividend withholding taxes that the Company is entitled to set off, divided by (ii)&nbsp;the then-applicable conversion price described below.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the Company&#146;s consolidated net leverage ratio is equal to or greater than 3.50 to 1.00 as of March&nbsp;31, 2023 or any quarter ending
thereafter, holders of Series B Preferred Stock will have the right to convert at a conversion price that equals 90% of the <FONT STYLE="white-space:nowrap">30-day</FONT> VWAP, during a <FONT STYLE="white-space:nowrap">60-day</FONT> conversion
window.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Holders of the Series B Preferred Stock will
also have the right to convert up to 25% of their shares of Series B Preferred Stock into Common Stock in the quarter following the completion of the Company&#146;s fiscal year ending December&nbsp;31, 2023, and each quarter ending thereafter at a
conversion price that equals a <FONT STYLE="white-space:nowrap">30-day</FONT> VWAP, during a <FONT STYLE="white-space:nowrap">60-day</FONT> conversion window.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Liquidation Preference:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">$1,000 per share of Series&nbsp;B Preferred
Stock</P></TD></TR></TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Liquidation Value:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In the event of a liquidation, holders of Series B Preferred Stock will receive the greater of (i)&nbsp;the
Liquidation Preference, plus any Series B Dividend accrued and unpaid at the time of such Liquidation, and (ii)&nbsp;the amount such holder of Series B Preferred Stock would have received upon conversion of its shares of Series B Preferred Stock
into shares of Common Stock using a conversion rate based on a fixed conversion price equal to $7.91.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Limitations on Redemption</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>and Conversion:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Unless and until the Stockholder Approval is obtained, the holders shall not have the right to acquire
shares of Common Stock pursuant to a redemption or conversion of the Series B Preferred Stock in a manner that would violate Nasdaq Listing Rule 5635. Conversion and redemption of Series B Preferred Stock are also subject to certain other beneficial
ownership limitations applicable to each of the Investors.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Limitation on Dividends and Redemptions of Junior Securities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Without the prior written consent of the holders of a majority of the outstanding shares of Series B
Preferred Stock, the Company shall not, nor shall it permit any subsidiary to, redeem or purchase or otherwise acquire directly or indirectly any junior securities, nor shall the Company directly or indirectly pay or declare any dividend upon any
junior securities (including any <FONT STYLE="white-space:nowrap">spin-off</FONT> or other dividend or distribution of properties, securities or any other assets).</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Voting Rights:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Holders of the Series B Preferred Stock shall not have any voting rights, other than with respect to:
(i)&nbsp;amendments to the Company&#146;s organizational documents that generally have an adverse effect on the Series&nbsp;B Preferred Stock as well as creation or issuance of senior or parity securities; (ii)&nbsp;issuance of additional Series B
Preferred Stock after the closing of the Financing Transaction; (iii)&nbsp;incurrence by the Company and its subsidiaries of indebtedness other than any indebtedness that would be permitted to be incurred under the Company&#146;s current credit
agreement, excluding (A)&nbsp;indebtedness incurred in connection with refinancing the Company&#146;s existing indebtedness outstanding, subject to certain limitations, and (B)&nbsp;indebtedness the net proceeds of which are contemporaneously used
to redeem all outstanding shares of Series B Preferred Stock; and (iv)&nbsp;the sale of assets outside the ordinary course of business of the Company, unless (A)&nbsp;such assets are sold for fair market value, (B) 85% of the consideration received
in connection with the asset sale is in the form of cash or cash equivalents and (C)&nbsp;the Company uses the net cash proceeds from such asset sale to permanently repay its indebtedness, and any net cash proceeds in excess of $25&nbsp;million are
used to redeem shares of Series B Preferred Stock and/or pay Series B Dividends.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Additional Consent Rights:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Until affiliates of Corre and Legion, respectively (the &#147;Specified Holders&#148;) cease to hold
specified amounts of Series B Preferred Stock, the Company shall not, without the prior consent of each Specified Holder, consummate or effect change in control transactions, other than (a)&nbsp;a transaction not approved by the Company&#146;s Board
of Directors prior to the consummation thereof or (b)&nbsp;a Qualifying Transaction.</P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Warrants </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Warrants will be exercisable, in full or in part, at any time prior to the seventh anniversary of their issuance, at an
exercise price of $12.00 per share, subject to customary anti-dilution adjustments in the event of future below market issuances, stock splits, stock dividends, combinations or similar events set forth in the Warrants. Unless and until the
Stockholder Approval is obtained, the holders shall not have the right to acquire shares of Common Stock in a manner that would violate Nasdaq Listing Rule 5635. In addition, certain other ownership limitations apply to each of the Investors. The
Warrant may be exercised for cash or on a cashless basis, based on an exercise price equal to the closing sale price on the immediately preceding trading day. In connection with a change of control transaction, any unexercised Warrants will be,
under certain circumstances, deemed to have been exercised on a cashless basis. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Warrant holders are entitled to participate in any dividend or other distribution by the Company to holders of shares of its Common Stock, on an
<FONT STYLE="white-space:nowrap">as-exercised</FONT> basis. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Registration Rights Agreement </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with the closing under the Purchase Agreement, the Investors will be granted certain customary registration
rights with respect to their shares of Common Stock, including those underlying the Series B Preferred Stock and Warrants, shares of Series B Preferred Stock and the Warrants pursuant to the terms of a registration rights agreement. The registration
rights agreement contains other customary terms and conditions, including mutual indemnifications by the Company and each Investor. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>ITEM&nbsp;3.02.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>UNREGISTERED SALE OF EQUITY SECURITIES. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The information contained in Item 1.01 of this Current Report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT>
regarding the offer and sale of the Series B Preferred Stock and Warrants, the Purchase Agreement and the terms of the Series&nbsp;B Preferred Stock is incorporated herein by reference. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The securities in the Financing Transaction were offered and will be issued and sold in reliance upon the exemption from the
registration requirements of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), set forth under Section&nbsp;4(a)(2) of the Securities Act relating to sales by an issuer not involving any public offering and in reliance on
similar exemptions under applicable state laws. Each Investor represented that it is an accredited investor and that it is acquiring the Series B Preferred Stock and Warrants for investment purposes and not with a view to any distribution of such
securities in violation of the United States federal securities laws. Neither this Current Report on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> nor the exhibit attached hereto is an offer to sell or the solicitation of an offer to buy the
securities described herein. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>ITEM&nbsp;7.01.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>REGULATION FD DISCLOSURE. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On December&nbsp;5, 2019, the Company issued a press release announcing the Financing Transaction. A copy of this press release
is included as Exhibit 99.1 to this Current <FONT STYLE="white-space:nowrap">Report&nbsp;on&nbsp;Form&nbsp;8-K.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information,
including the press release, furnished under this Item 7.01 shall not be deemed &#147;filed&#148; for the purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or otherwise subject to the
liabilities of that section, and shall not be deemed incorporated by reference into any other filing by the Company under the Exchange Act or the Securities Act of 1933, as amended, except as otherwise expressly stated in such filing. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>ITEM&nbsp;9.01.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>FINANCIAL STATEMENTS AND EXHIBITS. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>(d)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><I>Exhibits. </I></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="93%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit<BR>No.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d842748dex991.htm">Press Release issued by NN, Inc. dated December&nbsp;5, 2019</A></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Except for specific historical information, many of the matters discussed in this Current Report on Form
<FONT STYLE="white-space:nowrap">8-K</FONT> may express or imply projections of revenues or expenditures, statements of plans and objectives or future operations or statements of future economic performance. These, and similar statements, are
forward-looking statements concerning matters that involve risks, uncertainties and other factors which may cause the actual performance of NN, Inc. and its subsidiaries to differ materially from those expressed or implied by this discussion. All
forward-looking information is provided by the Company pursuant to the safe harbor established under the Private Securities Litigation Reform Act of 1995 and should be evaluated in the context of these factors. Forward-looking statements generally
can be identified by the use of forward-looking terminology such as &#147;assumptions&#148;, &#147;target&#148;, &#147;guidance&#148;, &#147;outlook&#148;, &#147;plans&#148;, &#147;projection&#148;, &#147;may&#148;, &#147;will&#148;,
&#147;would&#148;, &#147;expect&#148;, &#147;intend&#148;, &#147;estimate&#148;, &#147;anticipate&#148;, &#147;believe&#148;, &#147;potential&#148; or &#147;continue&#148; (or the negative or other derivatives of each of these terms) or similar
terminology. Factors which could materially affect actual results include, but are not limited to: the Company&#146;s ability to close the Financing Transaction on the terms described herein or in a timely manner, if at all; the Company&#146;s
failure to realize </I></P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>
the intended benefits of the Financing Transaction, the inability to pay cash dividends on the Series B Preferred Stock, thus increasing the dilutive impact of the Financing Transaction; the
inability of the Company to redeem the Series B Preferred Stock, in cash, if there has been no conversion, change in control or liquidity event; general economic conditions and economic conditions in the industrial sector, inventory levels,
regulatory compliance costs and the Company&#146;s ability to manage these costs, <FONT STYLE="white-space:nowrap">start-up</FONT> costs for new operations, debt reduction, competitive influences, risks that current customers will commence or
increase captive production, risks of capacity underutilization, quality issues, availability and price of raw materials, currency and other risks associated with international trade, the level of the Company&#146;s indebtedness, the restrictions
contained in the Company&#146;s debt agreements, the Company&#146;s ability to obtain financing at favorable rates, if at all, and to refinance existing debt as it matures, the Company&#146;s dependence on certain major customers, and the successful
implementation of the global growth plan including development of new products. Similarly, statements made herein and elsewhere regarding pending and completed transactions are also forward-looking statements, including statements relating to the
future performance and prospects of an acquired business, the expected benefits of an acquisition on the Company&#146;s future business and operations and the ability of the Company to successfully integrate recently acquired businesses or the
possibility that the Company will be unable to execute on the intended redeployment of proceeds from a divestiture, whether due to a lack of favorable investment opportunities or otherwise. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>For additional information concerning such risk factors and cautionary statements, please see the section titled &#147;Risk Factors&#148;
in the Company&#146;s periodic reports filed with the Securities and Exchange Commission, including, but not limited to, the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended
December&nbsp;31, 2018 and the Company&#146;s Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the three months ended September&nbsp;30, 2019. Except as required by law, we undertake no obligation to update or revise any
forward-looking statements we make in Current Reports on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> whether as a result of new information, future events or otherwise. </I></P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: December&nbsp;6, 2019 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>NN, INC.</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Matthew S. Heiter</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Matthew S. Heiter</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Senior Vice President, General Counsel</P></TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d842748dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.20em" ALIGN="right">


<IMG SRC="g842748g1206053827928.jpg" ALT="LOGO">
</P></TD></TR>
</TABLE> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g842748g1206053827787.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR FURTHER INFORMATION: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AT
ABERNATHY MACGREGOR </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Claire Walsh </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(General info) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(212) <FONT STYLE="white-space:nowrap">371-5999</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FOR
IMMEDIATE RELEASE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">December&nbsp;5, 2019 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NN, Inc. Announces $100 Million Private Placement of Series B Preferred Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Charlotte, N.C., December</B><B></B><B>&nbsp;5, 2019 &#150; </B>NN, Inc. (NASDAQ: NNBR), a diversified industrial company, today announced that it has
entered into an agreement with affiliates of Corre Partners Management, LLC and Legion Partners Asset Management, LLC, two large existing stockholders of NN, to make a $100&nbsp;million strategic investment in NN in the form of perpetual preferred
stock. NN expects to use the proceeds to repay the outstanding amounts on the Company&#146;s senior secured revolving credit facility, to pay any fees in connection with a possible extension of the maturity date of the Company&#146;s debt, and for
general corporate purposes. Closing is expected to occur on or before December&nbsp;10, 2019, subject to customary closing conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Warren Veltman,
interim President and CEO, commented, &#147;After concluding a comprehensive review of both public and private financing alternatives, we determined that this transaction expedites the <FONT STYLE="white-space:nowrap">de-levering</FONT> of our
business, improves our credit profile and provides liquidity. This transaction also provides flexibility with the option to redeem the Series B preferred stock with cash, which would minimize the dilution to our stockholders.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;In October of this year, we announced several initiatives to reduce costs and improve our cash flow, and in November we began a full strategic review of
our business aimed at identifying opportunities to further enhance shareholder value. This financing is an important step that will enhance our ability to invest in key customer relationships and support our operations as we explore strategic
alternatives. In short, we view this investment by two of our largest investors as a tremendous vote of confidence in us and our direction.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under
the securities purchase agreement, affiliates of Corre and Legion will purchase, in aggregate, $100&nbsp;million of Series B Convertible Preferred Stock and receive warrants with a 7 year term to purchase, in the aggregate, 1,500,000 shares of NN
common stock at $12.00 per share. The preferred stock includes the following attributes: perpetual in nature; a 10.625% dividend per annum, payable in </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
cash or additional shares of Series B Convertible Preferred Stock; redeemable, in cash (or, under certain circumstances, in stock), subject to the applicable redemption premium; convertible on
certain terms and conditions on or after December&nbsp;31, 2023; and subject to certain other rights and obligations. NN has also agreed to provide demand registration rights exercisable beginning on March&nbsp;31, 2021. Additional information
regarding the investment will be included in a Form <FONT STYLE="white-space:nowrap">8-K</FONT> to be filed by NN, Inc. with the Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan acted as exclusive placement agent to NN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
securities to be sold by NN, Inc. pursuant to the transactions described above have not been registered under the Securities Act of 1933 or any state securities laws and may not be offered or sold in the United States absent registration with the
U.S. Securities and Exchange Commission or an applicable exemption from such registration requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release does not constitute an offer
to sell or the solicitation of an offer to buy the securities, nor will there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the
securities laws of such jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NN, Inc., a diversified industrial company, combines advanced engineering and production capabilities with <FONT
STYLE="white-space:nowrap">in-depth</FONT> materials science expertise to design and manufacture high-precision components and assemblies for a variety of markets on a global basis. Headquartered in Charlotte, North Carolina, NN has 50 facilities in
North America, Europe, South America and China. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Except for specific historical information, many of the matters discussed in this press release may
express or imply projections of revenues or expenditures, statements of plans and objectives or future operations or statements of future economic performance. These, and similar statements, are forward-looking statements concerning matters that
involve risks, uncertainties and other factors which may cause the actual performance of NN, Inc. and its subsidiaries to differ materially from those expressed or implied by this discussion. All forward-looking information is provided by the
Company pursuant to the safe harbor established under the Private Securities Litigation Reform Act of 1995 and should be evaluated in the context of these factors. Forward-looking statements generally can be identified by the use of forward-looking
terminology such as &#147;assumptions&#148;, &#147;target&#148;, &#147;guidance&#148;, &#147;outlook&#148;, &#147;plans&#148;, &#147;projection&#148;, &#147;may&#148;, &#147;will&#148;, &#147;would&#148;, &#147;expect&#148;, &#147;intend&#148;,
&#147;estimate&#148;, &#147;anticipate&#148;, &#147;believe&#148;, &#147;potential&#148; or &#147;continue&#148; (or the negative or other derivatives of each of these terms) or similar terminology. Factors which could materially affect actual
results include, but are not limited to: the Company&#146;s ability to close the financing on the terms described herein or in a timely manner, if at all; the Company&#146;s failure to realize the intended benefits of the financing, the inability to
pay cash dividends on the preferred stock, thus increasing the dilutive impact of the financing; the inability of the Company to redeem the preferred stock, in cash, if there has been no conversion, change in control or liquidity event; general
economic conditions and economic conditions in the industrial sector, inventory levels, regulatory compliance costs and the Company&#146;s ability to manage these costs, <FONT STYLE="white-space:nowrap">start-up</FONT> costs for new operations, debt
reduction, competitive influences, risks that current customers will commence or increase captive production, risks of capacity underutilization, quality issues, availability and price of raw materials, currency and other risks associated with
international trade, the level of the Company&#146;s indebtedness, the restrictions contained in the Company&#146;s debt agreements, the Company&#146;s ability to obtain financing at favorable rates, if at all, and to refinance existing debt as it
matures, the Company&#146;s dependence on certain major customers, and the successful implementation of the global growth plan including development of new products. Similarly, statements made herein and elsewhere regarding pending and completed
transactions are also forward-looking statements, including statements relating to the future performance and prospects of an acquired business, the expected benefits of an acquisition on the Company&#146;s future business and operations and the
ability of the Company to successfully integrate recently acquired businesses or the possibility that the Company will be unable to execute on the intended redeployment of proceeds from a divestiture, whether due to a lack of favorable investment
opportunities or otherwise. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>For additional information concerning such risk factors and cautionary statements, please see the section titled
&#147;Risk Factors&#148; in the Company&#146;s periodic reports filed with the Securities and Exchange Commission, including, but not limited to, the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal
year ended December&nbsp;31, 2018 and the Company&#146;s Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the three months ended September&nbsp;30, 2019. Except as required by law, we undertake no obligation to update or
revise any forward-looking statements we make in our press releases, whether as a result of new information, future events or otherwise.. </I></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g842748g1206053827787.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g842748g1206053827787.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" != & # 2(  A$! Q$!_\0
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M4.CCN#6;XH\/6_B;0IM/G #D;HI,<HXZ&M\+7=&IKMU,,505:GIOT,OX:?\
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M,)0:GL<5&4XU$X;GU'+-'! \TKA(T4LS$\ #O6/H$<EVUSK=PA62^P(48<I
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GV3^M:%>;6Q4JAZ5'"PIC(HHX8DBB14C0!551@*!V I]%%<AUG__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g842748g1206053827928.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g842748g1206053827928.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !! -<# 2(  A$! Q$!_\0
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MDL_A2&SN23=:;(]C-GKF,X'_ ([MIG@ >1I>I6'\-EJ=Q"@]%W;@/UJ+3O\
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M>3<V4AB<_7'!_$54_P"$0U=?EC\9ZL$]'6-C^9% '53316\+33R)%&@RSNP
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4B@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g842748g1206095931913.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g842748g1206095931913.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !< %P# 2(  A$! Q$!_\0
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J*6(G+=CCAZ<>A4LM,M=/0BWB"LWWW/+-]3U-6\4M%8MW-[6"BBB@#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
